Emad Estemalik

Most-cited papers

1. Preventive treatment in migraine and the new US guidelines

   Emad Estemalik, S. Tepper

   2013Neuropsychiatric Disease and Treatment113 citations Open access

   Semantic Scholar

   Save

2. Safety and Efficacy of Occipital Nerves Stimulation for the Treatment of Chronic Migraines: Randomized, Double‐blind, Controlled Single‐center Experience

   N. Mekhail, Emad Estemalik, G. Azer, Kristina Davis +1 more

   2017Pain Practice71 citations

   Semantic Scholar

   Save

3. Implementation and Patient Experience of Outpatient Teleneurology

   Lindsay Ross, J. Bena, R. Bermel, L. McCarter +10 more

   2020Telemedicine journal and e-health24 citations Open access

   Semantic Scholar

   Save

4. A Comprehensive Review of the Use of Deep Brain Stimulation (DBS) in Treatment of Psychiatric and Headache Disorders

   Murat Altinay, Emad Estemalik, D. Malone

   2015Headache23 citations

   Semantic Scholar

   Save

5. Long‐Term Outcomes and Clinical Characteristics of Hypnic Headache Syndrome: 40 Patients Series From a Tertiary Referral Center

   N. Tariq, Emad Estemalik, B. Vij, Jennifer S. Kriegler +2 more

   2016Headache21 citations

   Semantic Scholar

   Save

6. Outcomes of Microvascular Decompression for Trigeminal Neuralgia with Purely Venous Compression: A Systematic Review and Meta-analysis

   Pranay Soni, T. Potter, P. Soni, Emad Estemalik +2 more

   2020Skull Base17 citations

   Semantic Scholar

   Save

7. Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER).

   A. Ambrosini, Emad Estemalik, J. Pascual, M. Rettiganti +3 more

   2022Journal of Managed Care & Specialty Pharmacy11 citations

   Semantic Scholar

   Save

8. Implementation and Patient Experience with Outpatient Subspecialty Teleneurology Visits at a Single Academic Institution Over Four Years (Plen01.004)

   Lindsay Ross, James Bena, R. Bermel, L. Mccarter +10 more

   2019Neurology6 citations

   Semantic Scholar

   Save

9. Effects of galcanezumab on acute medication use and health care resource utilization in treatment-resistant migraine: results from randomized, double blind, placebo-controlled clinical trial, conquer

   A. Ambrosini, Emad Estemalik, J. Pascual, M. Rettiganti +3 more

   2020Headache Medicine1 citations Open access

   Semantic Scholar

   Save

10. Real-world Improvements in Cognitive Symptoms After Eptinezumab Treatment in Patients in Whom ≥1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for the Ongoing INFUSE Study (P1-15.006)

    Emad Estemalik, R. Lipton, S. Soni-Brahmbhatt, Stephane Regnier +4 more

    2026Neurology0 citations

    Semantic Scholar

    Save

11. Patient-reported outcomes from a real-world evidence study in individuals with migraine initiating eptinezumab after ≥1 prior calcitonin gene-related peptide (CGRP)-targeted preventive therapy

    Amaal J. Starling, Stephane Regnier, S. Soni-Brahmbhatt, Susanne F. Awad +4 more

    2026Cephalalgia Reports0 citations Open access

    Semantic Scholar

    Save

12. Real-world Effectiveness of Eptinezumab in Patients in Whom ≥1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for an Ongoing Prospective Study (P10-15.006)

    Emad Estemalik, Stephane Regnier, S. Soni-Brahmbhatt, Susanne F. Awad +6 more

    2026Neurology0 citations

    Semantic Scholar

    Save